Full Transcript of Medimmune’s 3Q05 Conference Call — Prepared Remarks (MEDI)

Here’s the entire text of the prepared remarks from Medimmune’s (ticker: MEDI) Q3 2005 conference call. The Q&A is here. We recognize that this transcript may contain inaccuracies - if you find any, please post a comment below and we’ll incorporate your corrections. And please note: this conference call transcript is a Seeking Alpha product, so feel free to link to it but reproduction is not permitted without the explicit permission of Seeking Alpha.

Executives:

David Mott, President and Chief Executive Officer
Lota Zoth, Chief Financial Officer
James Young, President, Research and Development
Armando Anido, Head of Sales and Marketing
Edward Connor, Chief Medical Officer
Ed Mathers, Senior Vice President

Analysts:

Ian Somaiya, Thomas Weisel Partners
Jeff Roger, Stanford Bear Stearns
Lee Zong, Banc of America
Joel Sendek, Lazard Capital Market
Craig Parker, Lehman Brothers
Elise Wang, Citi Group
Mark Schoenebaum, Bear Stearns
Mack Tufee, Black Diamond Research
Steven Harr, Morgan Stanley
May-Kin Ho, Goldman Sachs
Philip Nadeau, Sg Cowen
Laine Holman, Sigma Capital

Presentation

[Operator]

Ladies and Gentleman and welcome to the MedImmune 3rd Quarter Earnings Conference Call. My name is Ann Marina I will be your coordinator for today. At this time all participants are in a listen only mode. We will be facilitating a Question and Answer sessions after the presentation of today’s conference. If any time during the call require any assistance please “*